Zim Laboratories
Global Pharma
Strategic Partnership Formalized to Advance Global Health Goals
ZIM Laboratories, a leading India-based pharmaceutical company specializing in innovative drug delivery systems, has entered into a strategic partnership with Globalpharma, a prominent UAE-based pharmaceutical manufacturer and a subsidiary of Dubai Investments. This long-term collaboration focuses on the licensing, supply, and technology transfer of ZIM’s patented Oral Thin Film (OTF) technology for the GCC pharmaceutical market. Under the agreement, ZIM will provide EU-GMP certified formulations, while Globalpharma will manage local production, regulatory approvals, and market commercialization across the Gulf region. This pharma alliance combines R&D-driven innovation with regional manufacturing expertise to enhance medicine accessibility, improve patient compliance, and accelerate the availability of affordable, high-quality pharmaceuticals and nutraceuticals across the Middle East and North Africa.
Zim Laboratories
ZIM Laboratories is a research-driven pharmaceutical company specializing in innovative drug delivery solutions. Headquartered in India, the company focuses on developing and manufacturing differentiated generic formulations in various oral solid dosage forms, including tablets, capsules, pellets, and oral thin films. With a strong emphasis on patient convenience, affordability, and quality, ZIM Laboratories serves both regulated and emerging markets across the globe. Its in-house R&D capabilities and proprietary technologies enable it to offer unique products that enhance treatment compliance and accessibility, making it a trusted partner in advancing global healthcare.
Global Pharma
Global Pharma is a Dubai-based pharmaceutical manufacturer operating under Dubai Investments PJSC. Focused on meeting regional healthcare needs, the company specializes in producing a wide range of high-quality pharmaceuticals and nutraceuticals. Leveraging modern facilities and regulatory expertise, it supports scalable manufacturing, efficient distribution, and market access across the GCC region. Known for strategic collaborations and a drive toward innovation, its vision centers on delivering affordable, patient-friendly medicines while contributing to the growth and self-reliance of the Middle East healthcare ecosystem.
